This compound is a pharmaceutical intermediate featuring a highly substituted piperidine ring system with trifluoroethyl groups and a tert-butyl carbamate moiety. It is characterized by moderate polarity and lipophilicity, with defined stereochemistry.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1456803-34-1
3-amino-6-methyl-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-2-one;4-nitrobenzoic acid
pharmaceutical intermediate
Tert-Butyl ((5S,6R)-6-methyl-2-oxo-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate
pharmaceutical intermediate
3-(2,3,6-Trifluorophenyl)but-3-en-2-one
pharmaceutical intermediate
Spiro[6H-cyclopenta[b]pyridine-6,3'-[3H]pyrrolo[2,3-b]pyridin]-2'(1'H)-one, 3-chloro-1'-(1,1-dimethylethyl)-5,7-dihydro-, (3'R)-
pharmaceutical intermediate
1,1-Dimethylethyl N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]carbamate
research compound
(3S,5S,6R)-3-Amino-6-methyl-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-2-one 4-methylbenzoate
pharmaceutical intermediate
(3S,5S,6R)-3-amino-6-methyl-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-2-one hydrochloride
research reagent
(3S,5S,6R)-3-Amino-6-methyl-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-2-one
pharmaceutical intermediate
tert-butyl N-[(5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl]-N-(2,2,2-trifluoroethyl)carbamate
OMXCJWOWIGTTFZ-CWSLVUQWSA-N
C[C@@H]1[C@@H](CC(C(=O)N1CC(F)(F)F)N(CC(F)(F)F)C(=O)OC(C)(C)C)C2=CC=CC=C2
—